Research Funding

Grant Title Grantor Amount Award Date
David L. Suskind, MD
Fecal Microbial Therapy in Inflammatory Bowel Disease Academic Enrichment Fund $20,000 2012
Ghassan T. Wahbeh, MD
Genome-Wide Association (GWA) identified predictors of response to Anti-TNFα Therapy in Pediatric IBD NIH NIDDK funding 2010
Ghassan T. Wahbeh, MD
A Phase 2, open-label, multicenter study to assess the safety and efficacy of certolizumab pegol in children and adolescents with active Crohn’s disease (NURTURE Study) UCB 2010
Simon Horslen, MB ChB
Childhood Liver Disease Research and Education Network Clinical Center in SeattleRole NIH/NIDDK July 1, 2009
Simon Horslen, MB ChB
Pilot study of the safety and immunogenicity of a rotavirus vaccine in infants at risk for intestinal failure Thrasher Research Fund May 14, 2009
Karen Murray, MD
A Phase 3, Randomized, Double-Blind Evaluation of the Antiviral Efficacy, Safety, and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Adolescents with Chronic Hepatitis B Infection Gilead Sciences, Inc. $56,849.00 Jan. 1, 2009
Karen Murray, MD
Limited Competition: Continuation of the Non-alcoholic Steatohepatitis Clinical Research Network (NASH CRN) NIH $225,207.00 Jan. 1, 2009
Karen Murray
Childhood Liver Disease Research and Education Network Clinical Center in Seattle NIH NIDDK $1,557,754.00 Jan. 1, 2009
David L. Suskind, MD
Curcumin in Pediatric Ulcerative colitis: A forced dose titration study University of Washington Institute for Translational Health Science $24,000 July 2008 - Aug. 2009
Simon Horslen, MB ChB
Intestinal failure in children: A contemporary retrospective review by the Pediatric Intestinal Failure Consortium NIH April 1, 2008
Karen Murray, MD
BARC CRN, Biliary atresia research consortium NIH NIDDK $95,266.00 Jan. 1, 2008
Karen Murray, MD
Clinical Research Network in Hepatitis B Virus NIH $311,878.00 Jan. 1, 2008
Ghassan T. Wahbeh, MD
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients with Inflammatory Bowel Disease Centocor $15911 2008
Simon Horslen, MB ChB
A Multi-Center Group to Study Acute Liver Failure in Children NIH/NIDDK Sept. 15, 2005
David L. Suskind, MD
Maternal microchimerism in Inflammatory Bowel Disease Broad Foundation Medical Research Grant $142,000 July 2005 - July 2007
Simon Horslen, MB ChB
Studies in Pediatric Liver Transplantation NIH May 6, 2005
Karen Murray, MD
A phase 3 double-blind, randomized, placebo-controlled study of the safety and efficacy of Adefovir Dipivoxil in children and adolescents (age 2 to under 18) with chronic hepatitis B Gilead Sciences, Inc. $128,327.00 Jan. 1, 2004
Karen Murray, MD
Pegylated interferon + - ribavirin for children with HCV FDA-OPD-2002 Clinical Studies of Safety and Effectiveness of Orphan Products $99,650.00 Jan. 1, 2003
David L. Suskind, MD
Maternal microchimerism in Biliary Atresia University of California San Francisco of Medicine Research, Evaluation and Allocation Committee (REAC) Grant $16,000 June 2002 - June 2003
Karen Murray, MD
CD4+ T-cell immunity in mother-child pairs infected with hepatitis C virus Research Endorsement Fund $30,000.00 Jan. 1, 2002
Karen Murray, MD
Pediatric Acute liver failure study group NIH/NIDDK $16,000.00
David L. Suskind, MD
Fecal Microbial Therapy in Pediatric Crohn's Disease Cuyamaca Foundation $70,000